BASIC AND CLINICAL STUDIES ON FLEROXACIN IN ORAL SURGERY

We performed experimental and clinical studies on fleroxacin, a new synthetic antimicrobial agent for oral use, in the field of oral surgery. 1. Fleroxacin, at 200mg, was administered to 135 patients, and the concentrations in blood of fleroxacin revealed 0.45-4.43μg/ml at 141-370 min, after adminis...

Full description

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 38; no. Supplement2; pp. 657 - 665
Main Authors MORISHIMA, TAKASHI, TOMITA, FUMISADA, SAKAMOTO, HARUO, OTA, YOSHIHIDE, SASAKI, JIRO, MORIHANA, TAKEFUMI, KANEKO, AKIHIRO
Format Journal Article
LanguageEnglish
Japanese
Published Japanese Society of Chemotherapy 1990
公益社団法人 日本化学療法学会
Subjects
Online AccessGet full text
ISSN0009-3165
1884-5894
DOI10.11250/chemotherapy1953.38.Supplement2_657

Cover

Abstract We performed experimental and clinical studies on fleroxacin, a new synthetic antimicrobial agent for oral use, in the field of oral surgery. 1. Fleroxacin, at 200mg, was administered to 135 patients, and the concentrations in blood of fleroxacin revealed 0.45-4.43μg/ml at 141-370 min, after administration in 55 subjects. 2. A clinical study was conducted in 53 patients with odontogenic infections. The efficacy rate, judged by comparative score evaluation, was 81.6%, while that by doctors was 73.5%. Causative bacteria were isolated from 17 patients. In five cases, side-effects (insomnia, dizziness, headache) occurred. Abnormal changes in laboratory findings were noted in two cases (mild increase in eosinophils and slight elevation of BUN, s-Cr).
AbstractList We performed experimental and clinical studies on fleroxacin, a new synthetic antimicrobial agent for oral use, in the field of oral surgery. 1. Fleroxacin, at 200mg, was administered to 135 patients, and the concentrations in blood of fleroxacin revealed 0.45-4.43μg/ml at 141-370 min, after administration in 55 subjects. 2. A clinical study was conducted in 53 patients with odontogenic infections. The efficacy rate, judged by comparative score evaluation, was 81.6%, while that by doctors was 73.5%. Causative bacteria were isolated from 17 patients. In five cases, side-effects (insomnia, dizziness, headache) occurred. Abnormal changes in laboratory findings were noted in two cases (mild increase in eosinophils and slight elevation of BUN, s-Cr).
We performed experimental and clinical studies on fleroxacin, a new synthetic antimicrobial agent for oral use, in the field of oral surgery.1. Fleroxacin, at 200mg, was administered to 135 patients, and the concentrations in blood of fleroxacin revealed 0.45-4.43μg/ml at 141-370 min, after administration in 55 subjects.2. A clinical study was conducted in 53 patients with odontogenic infections. The efficacy rate, judged by comparative score evaluation, was 81.6%, while that by doctors was 73.5%. Causative bacteria were isolated from 17 patients. In five cases, side-effects (insomnia, dizziness, headache) occurred. Abnormal changes in laboratory findings were noted in two cases (mild increase in eosinophils and slight elevation of BUN, s-Cr). 新合成抗菌剤fleroxacinについて口腔外科領域への適応を基礎的, 臨床的に検討した。1.135例の抜歯予定患者を対象に, 本剤を200mg服用させ, 抜歯時に抜歯創部血液および唾液を採取し, その濃度を測定した。薬剤濃度は個人差はみられるが, 血中濃度で服用後141~370分の55例では, 0.45~4.43μg/mlの濃度が得られた。2.口腔外科領域の急性歯性感染症53例に本剤を使用した。臨床効果は点数判定では81.6%, 主治医判定では73.5%の有効率が得られた。副作用は5例に認められ, 主な副作用は不眠, めまいであった。臨床検査値異常は2例に認められ, 好酸球上昇1例, BUNおよび血清クレアチニンの上昇1例であった。
Author MORISHIMA, TAKASHI
KANEKO, AKIHIRO
SAKAMOTO, HARUO
OTA, YOSHIHIDE
MORIHANA, TAKEFUMI
SASAKI, JIRO
TOMITA, FUMISADA
Author_FL 森島 丘
坂本 春生
森鼻 健史
佐々木 次郎
富田 文貞
金子 明寛
太田 嘉英
Author_FL_xml – sequence: 1
  fullname: 金子 明寛
– sequence: 2
  fullname: 坂本 春生
– sequence: 3
  fullname: 森島 丘
– sequence: 4
  fullname: 太田 嘉英
– sequence: 5
  fullname: 佐々木 次郎
– sequence: 6
  fullname: 森鼻 健史
– sequence: 7
  fullname: 富田 文貞
Author_xml – sequence: 1
  fullname: MORISHIMA, TAKASHI
  organization: Department of Oral Surgery, School of Medicine, Tokai University
– sequence: 1
  fullname: TOMITA, FUMISADA
  organization: Department of Dentistry and Oral Surgery, Ashikaga Red Cross Hospital
– sequence: 1
  fullname: SAKAMOTO, HARUO
  organization: Department of Oral Surgery, School of Medicine, Tokai University
– sequence: 1
  fullname: OTA, YOSHIHIDE
  organization: Department of Oral Surgery, School of Medicine, Tokai University
– sequence: 1
  fullname: SASAKI, JIRO
  organization: Department of Oral Surgery, School of Medicine, Tokai University
– sequence: 1
  fullname: MORIHANA, TAKEFUMI
  organization: Department of Dentistry and Oral Surgery, Ashikaga Red Cross Hospital
– sequence: 1
  fullname: KANEKO, AKIHIRO
  organization: Department of Oral Surgery, School of Medicine, Tokai University
BackLink https://cir.nii.ac.jp/crid/1390001206285853568$$DView record in CiNii
BookMark eNpdUE1rg0AQXUoKTdP8Bw891nRn1_06WmNTQRQ0gfa03cjaGBIjag_591XSQwgMM8zMew_ee0ST-lRbhF4ALwAIw6_Fzh5P_c62pjmDYnRB5SL_bZqDPdq6J5ozcYemIKXnMqm8CZpijJVLgbMHNO-6aosxAOZEkimSb34eBY6fLJ0gjpIo8GMnX2-WUZg7aeK8x2GWfvpBlDhDpdn43WSrMPt6QvelOXR2_j9naPMeroMPN05Xo4q7Jx7tXWmwFRgU4NKAsNRIhRWnBcPSM7w0BRVbTkpWCkIKrCxRw4EJwRiH0oqSztDzRbeuKl1UYweqBkdARgtMMsq4HGDfF9i-682P1U1bHU171qbtq-Jg9W1omkp9HdrNOmR4RTWttjX9AzQtby8
ContentType Journal Article
Copyright Japanese Society of Chemotherapy
Copyright_xml – notice: Japanese Society of Chemotherapy
DBID RYH
DOI 10.11250/chemotherapy1953.38.Supplement2_657
DatabaseName CiNii Complete
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate 口腔外科領域におけるFleroxacinの基礎的・臨床的検討
DocumentTitle_FL 口腔外科領域におけるFleroxacinの基礎的・臨床的検討
EISSN 1884-5894
EndPage 665
ExternalDocumentID 130004197183
article_chemotherapy1953_38_Supplement2_38_Supplement2_657_article_char_en
GroupedDBID 53G
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
DIK
JSF
JSH
KQ8
RJT
RZJ
ZOHVM
RYH
ID FETCH-LOGICAL-j243t-8a0e701910fa17e3a890963c5084a6fac37b62f5f722c09e2937b5775561fe7f3
ISSN 0009-3165
IngestDate Thu Jun 26 23:45:16 EDT 2025
Wed Sep 03 06:11:04 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue Supplement2
Language English
Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j243t-8a0e701910fa17e3a890963c5084a6fac37b62f5f722c09e2937b5775561fe7f3
OpenAccessLink https://www.jstage.jst.go.jp/article/chemotherapy1953/38/Supplement2/38_Supplement2_657/_article/-char/en
PageCount 9
ParticipantIDs nii_cinii_1390001206285853568
jstage_primary_article_chemotherapy1953_38_Supplement2_38_Supplement2_657_article_char_en
PublicationCentury 1900
PublicationDate 1990-00-00
PublicationDateYYYYMMDD 1990-01-01
PublicationDate_xml – year: 1990
  text: 1990-00-00
PublicationDecade 1990
PublicationTitle CHEMOTHERAPY
PublicationTitleAlternate Chemother.
PublicationTitle_FL CHEMOTHERAPY
Chemother
PublicationYear 1990
Publisher Japanese Society of Chemotherapy
公益社団法人 日本化学療法学会
Publisher_xml – name: Japanese Society of Chemotherapy
– name: 公益社団法人 日本化学療法学会
References 1) AOYAMA H, INOUE M and MITSUHASHI S: In-vitro and in-vivo antibacterial activity of fleroxacin, a new fluorinated quinolone. J Antimicrob Chemother 22 (Suppl. D): 99-114, 1988
5) 森島丘, 他: 口腔外科領域におけるNY-198の基礎的・臨床的検討. Chemotherapy 36 (Suppl. 2): 1388-1401, 1988
2) HIRAI K, AOYAMA H, HOSAKA M, OOMORI Y, NIWATA Y, SUZUE S and IRIKURA T: In-vitro and In-vivo Antibacterial Activity of AM-833, a new Quinolone Derivative. Antimicrob Agent Chemother 29: 1059-1066, 1986
4) 高井宏, 久野吉雄, 道健一, 佐々木次郎: 歯性感染症に対する抗生物質の効果判定基準について. 歯薬療法1: 122-160, 1982
6) 森鼻健史, 坂本春生, 植松正孝, 山田善雄, 佐々木次郎, 椎木一雄: 口腔外科領域における DL-8280の基礎的・臨床的検討. Chemotherapy 32 (Suppl. 1): 1070-1083, 1984
3) 谷村弘, 副島林造: 第37回日本化学療法学会西日本支部総会, 新薬シンポジウム. AM-833 (Fleroxacin), 和歌山, 1989
7) 佐々木次郎, 関口登貴子, 植松正孝, 森島丘, 太田嘉英, 森鼻健史, 金子明寛, 富田文貞, 近 内寿勝: 口腔外科領域におけるT-3262の基礎的・臨床的検討. Chemotherapy 36 (Suppl. 9): 1488-1507, 1988
References_xml – reference: 4) 高井宏, 久野吉雄, 道健一, 佐々木次郎: 歯性感染症に対する抗生物質の効果判定基準について. 歯薬療法1: 122-160, 1982
– reference: 5) 森島丘, 他: 口腔外科領域におけるNY-198の基礎的・臨床的検討. Chemotherapy 36 (Suppl. 2): 1388-1401, 1988
– reference: 7) 佐々木次郎, 関口登貴子, 植松正孝, 森島丘, 太田嘉英, 森鼻健史, 金子明寛, 富田文貞, 近 内寿勝: 口腔外科領域におけるT-3262の基礎的・臨床的検討. Chemotherapy 36 (Suppl. 9): 1488-1507, 1988
– reference: 1) AOYAMA H, INOUE M and MITSUHASHI S: In-vitro and in-vivo antibacterial activity of fleroxacin, a new fluorinated quinolone. J Antimicrob Chemother 22 (Suppl. D): 99-114, 1988
– reference: 6) 森鼻健史, 坂本春生, 植松正孝, 山田善雄, 佐々木次郎, 椎木一雄: 口腔外科領域における DL-8280の基礎的・臨床的検討. Chemotherapy 32 (Suppl. 1): 1070-1083, 1984
– reference: 3) 谷村弘, 副島林造: 第37回日本化学療法学会西日本支部総会, 新薬シンポジウム. AM-833 (Fleroxacin), 和歌山, 1989
– reference: 2) HIRAI K, AOYAMA H, HOSAKA M, OOMORI Y, NIWATA Y, SUZUE S and IRIKURA T: In-vitro and In-vivo Antibacterial Activity of AM-833, a new Quinolone Derivative. Antimicrob Agent Chemother 29: 1059-1066, 1986
SSID ssib001106282
ssj0000626693
ssib058492509
ssib005879733
ssib008506721
Score 1.2098137
Snippet We performed experimental and clinical studies on fleroxacin, a new synthetic antimicrobial agent for oral use, in the field of oral surgery. 1. Fleroxacin, at...
We performed experimental and clinical studies on fleroxacin, a new synthetic antimicrobial agent for oral use, in the field of oral surgery.1. Fleroxacin, at...
SourceID nii
jstage
SourceType Publisher
StartPage 657
SubjectTerms Fleroxacin
ニューキノロン系抗菌剤
口腔外科領域感染症
Title BASIC AND CLINICAL STUDIES ON FLEROXACIN IN ORAL SURGERY
URI https://www.jstage.jst.go.jp/article/chemotherapy1953/38/Supplement2/38_Supplement2_657/_article/-char/en
https://cir.nii.ac.jp/crid/1390001206285853568
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX CHEMOTHERAPY, 1990/11/30, Vol.38(Supplement2), pp.657-665
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Rj5QwEG72zsT4ctGo8dQzPPiGrECBlse64QS5pYpssvdECtsme4nr5bL3oL_eKWVZ9jTxNCENW5amdD6mX4fODEJvXSz0blzfUbGSThAFxBER9hyvocBuQ7mKlDboz4soXQSfluFyMrkde5dsm2n7849-Jf8jVagDuWov2X-Q7NAoVMA5yBdKkDCU95LxB_YVBlEHiJpdZIWJbGAYns0L-_wiKfmSzbLChoOX-uqi_JiUB4xUx0TgVZqU7PPAanNWJDm3WZ6lWckHIwzLGfyV2ykrF0PtnJfa5jVndgXX4Www21bMvuRQkWZ9mu1V723n7lU-TNU6BeawebTbHCK_9W5hPw50agya3GR8mEqjRikNnJCa9MU7PYvpCE9dztLOAOqP1GdkglX3M3Fk2vxdyQNtA9G0o-7oj4FTTGHCGZqth8YOwmnrz3du4MUwJ-Mj9MAnxNM7QfMvezWkg_jtosaZCR1YTDzk5NPP-hC92_Xk_T36AfTmCsi-juJwtFmvRwymeoxO-qWHxQyOnqCJ3DxFtMOQBRiydhiyegxZvLD2GLLg0Biyegw9Q4vzpJqlTp9Nw7nyA7x1qHCljr3vuUp4RGJBY1i-4hYYeiAiJVpMmshXoSK-37qxBB5ImpAQnT9VSaLwc3S8-b6RL5ClYBWus141TesGRKzisG1iugJyKHwPK3mKLs3j1tcmZErdvyL13bGqMa1HULj7E4ZudKu4gZf-FJ3BCNbtWpewfOlMqZ0jMBDPMKIv_3L9FXqkgW6saK_R8fbmVp4Br9w2bzoU_AJprGmW
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=BASIC+AND+CLINICAL+STUDIES+ON+FLEROXACIN+IN+ORAL+SURGERY&rft.jtitle=CHEMOTHERAPY&rft.au=KANEKO+AKIHIRO&rft.au=SAKAMOTO+HARUO&rft.au=MORISHIMA+TAKASHI&rft.au=OTA+YOSHIHIDE&rft.date=1990&rft.pub=Japanese+Society+of+Chemotherapy&rft.issn=0009-3165&rft.eissn=1884-5894&rft.volume=38&rft.issue=Supplement2&rft.spage=657&rft.epage=665&rft_id=info:doi/10.11250%2Fchemotherapy1953.38.supplement2_657&rft.externalDocID=130004197183
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-3165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-3165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-3165&client=summon